DCF — CHI ST LUKES HEALTH MEMORIAL LUFKIN
Enterprise Value: $-351.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-351.6M
Enterprise Value
$-109.2M
PV of Cash Flows
$-242.4M
PV of Terminal Value
$-390.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $158.8M | $-23.0M | -15.0% | $-29.7M | $-27.0M |
| Year 2 | $163.5M | $-22.1M | -14.0% | $-29.0M | $-24.0M |
| Year 3 | $168.4M | $-21.1M | -13.0% | $-28.2M | $-21.2M |
| Year 4 | $173.5M | $-20.8M | -12.0% | $-28.2M | $-19.2M |
| Year 5 | $178.7M | $-21.0M | -12.0% | $-28.6M | $-17.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-351.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$154.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15006455017056683
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5